We are developing a portfolio of first-in-class gene therapies based on our proprietary nano-delivery technology. Indications are prioritized according to medical needs, technical feasibility, safety, and timing considerations.
Colorectal Cancer, Pancreatic Cancer
Hair Loss, Crohn’s Disease
We develop novel gene-editing technologies for the betterment and blissfulness of human life.
08 Oct, 2020
기준일 설정 공고
14 Aug, 2020
2020년 제2회 임시주주총회 소집 공고
23 Jul, 2020
혁신성장 코리아 - 한국경제 TV
U-space 2 A-505,670, Daewangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of KoreaT +82-031-628-6886 | F +82-031-628-6887Copyright © 2019 MOOGENE MEDI Co., Ltd. All Rights Reserved.